DOI: 10.1055/s-00000134

Diabetologie und Stoffwechsel

References

Zinman B, Inzucchi SE, Lachin JM. et al.
Rationale, design, and baseline characteristics of a randomized, placebo-controlled cardiovascular outcome trial of empagliflozin (EMPA-REG OUTCOME™).

Cardiovasc Diabetol 2014;
13: 102

Download Bibliographical Data

Access: